ARTICLE | Company News
Pfizer, ChemRar deal
July 9, 2012 7:00 AM UTC
Pfizer granted ChemRar's SatRx LLC company exclusive rights outside China to develop and commercialize Pfizer's gosogliptin ( PF-00734200) to treat Type II diabetes as monotherapy or in combination w...